Safety and Effectiveness Using 8 Weeks of Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis: The CREST Study
CREST 研究:在未接受过治疗的丙型肝炎病毒感染且伴有代偿性肝硬化的患者中使用格卡瑞韦/哌仑他韦治疗 8 周的安全性和有效性
期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-022-02158-6
Cornberg, Markus; Ahumada, Adriana; Aghemo, Alessio; Andreoni, Massimo; Bhagat, Abhi; Butrymowicz, Isabel; Carmiel, Michal; Chodick, Gabriel; Conway, Brian; Song, Yanna; Gasbarrini, Antonio; Hüppe, Dietrich; Plaza, Francisco Jorquera; Lampertico, Pietro; Alonso, Maria Luisa Manzano; Myles, Lindsay; Persico, Marcello; Ramji, Alnoor; Sarrazin, Christoph; Villa, Erica; Weil, Clara; Otano, Juan Isidro Uriz